2026 NPPES data Pulmonary Disease Physician NPI 1881613057 MD
Verify on CMS →

GHADA BOURJEILY, MD

Pulmonary Disease Physician in PROVIDENCE, Rhode Island. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
403
Medicare Part D claims · 50 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
38%
generic claims · 62% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

GHADA BOURJEILY, MD filed 403 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in PROVIDENCE, Rhode Island, prescribing 38% generic.

403
Part D claims, 2023
38%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

GHADA BOURJEILY, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

403 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

GHADA BOURJEILY, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about GHADA BOURJEILY, MD?

Quality data not reported

NPI registry status

Active

Issued 07/19/2006

NPI 1881613057

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

403 72% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

Specialty distribution in Rhode Island

How Pulmonary Disease Physician compares to other specialties among Rhode Island providers

Rhode Island providers

Pulmonary Disease Physician share within Rhode Island

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within Rhode Island

Specialty board-certification context

Estimated specialty board-certified rate — Pulmonary Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pulmonary Disease Physician ABMS/AOA estimate

Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GHADA BOURJEILY, MD appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD credentials at 593 EDDY ST, PROVIDENCE, RI, 02903, with a listed phone of (401) 793-5700. NPI 1881613057 was issued on 07/19/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOURJEILY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 403 prescription claims written by this provider, covering 50 Medicare beneficiaries and totaling roughly $137K in drug spend, split 62% brand-name and 38% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

593 EDDY ST
PROVIDENCE, RI 02903

Provider Details

NPI 1881613057
Specialty Pulmonary Disease Physician
Credentials MD
Gender Female
NPI Issued 07/19/2006

Hospital and facility affiliations

Facilities where GHADA BOURJEILY, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

RHODE ISLAND HOSPITAL
★★★★☆ 4/5
PROVIDENCE, RI
Acute Care Hospitals
CMS CCN: 410007

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Brand-heavy

GHADA BOURJEILY, MD — brand share 62.0%
Specialty average (est.)

62% brand-name claims vs 38% generic, on 403 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

403
Total Claims
$137K
Total Drug Cost
50
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
520
Total Day Supply
14,847
Brand vs Generic
62% brand / 38% generic
Brand Drug Cost
$127K
Generic Drug Cost
$11K

Patient Demographics

Average Patient Age
70.8 years
Avg HCC Risk Score
1.33

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What GHADA BOURJEILY, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Montelukast Sodium
48
Albuterol Sulfate Hfa
Albuterol Sulfate
41
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
35
Roflumilast
25
Wixela Inhub
Fluticasone Propion/Salmeterol
23
Symbicort
Budesonide/Formoterol Fumarate
22
Fluticasone Propionate
19
Ventolin Hfa
Albuterol Sulfate
19
Budesonide-Formoterol Fumarate
Budesonide/Formoterol Fumarate
18
Advair Diskus
Fluticasone Propion/Salmeterol
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How GHADA BOURJEILY, MD fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

GHADA BOURJEILY, MD's 403 claims are below the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in Rhode Island

Other clinicians with the same primary specialty enrolled in Rhode Island, drawn from the same CMS NPPES roster as BOURJEILY.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is GHADA BOURJEILY, MD's specialty?
GHADA BOURJEILY, MD specializes in Pulmonary Disease Physician and practices in PROVIDENCE, Rhode Island. Credentials: MD.
How much does GHADA BOURJEILY, MD prescribe under Medicare Part D?
In 2023, GHADA BOURJEILY, MD wrote 403 Medicare Part D claims totaling $137K in drug costs for 50 beneficiaries.
Where is GHADA BOURJEILY, MD located?
GHADA BOURJEILY, MD is located at 593 EDDY ST, PROVIDENCE, RI, 02903. Phone: (401) 793-5700.
What is GHADA BOURJEILY, MD's NPI number?
GHADA BOURJEILY, MD's National Provider Identifier (NPI) is 1881613057, issued on 07/19/2006.
Does GHADA BOURJEILY, MD prescribe more brand-name or generic drugs?
GHADA BOURJEILY, MD's prescribing is 62% brand-name and 38% generic drugs by claim count, with $127K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does GHADA BOURJEILY, MD prescribe most often?
Based on 2023 Medicare Part D data, GHADA BOURJEILY, MD's most frequently prescribed drugs include Montelukast Sodium, Albuterol Sulfate Hfa, Trelegy Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GHADA BOURJEILY, MD accept Medicare?
GHADA BOURJEILY, MD appears in CMS Medicare data with 403 Part D claims and 50 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GHADA BOURJEILY, MD's credentials?
GHADA BOURJEILY, MD's NPI is 1881613057 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology